A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI

Esmee Oussoren1, Johannes H J M Bessems2, Virginie Pollet2

  • 1Department of Pediatrics, Center for Lysosomal and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.

Insights

Hip abnormalities in Mucopolysaccharidosis type VI (MPS VI) are present from early childhood, causing significant disability. These progressive hip issues in MPS VI patients impact mobility and require careful management strategies.

Area of Science:

  • Orthopedics
  • Genetics
  • Pediatrics

Background:

  • Mucopolysaccharidosis type VI (MPS VI) is a rare genetic disorder.
  • Hip problems in MPS VI patients lead to severe disability and impact quality of life.
  • Limited data exists on the natural history of hip disease in MPS VI, hindering treatment decisions.

Purpose of the Study:

  • To investigate the longitudinal development of hip pathology in patients with MPS VI.
  • To correlate radiographic findings with clinical manifestations of hip disease.
  • To provide data for informed surgical intervention timing and type.

Main Methods:

  • Prospective follow-up study involving 14 enzyme replacement therapy (ERT)-treated MPS VI patients.
  • Annual or biennial pelvic and hip radiographs (AP pelvis, frog leg lateral) analyzed quantitatively and qualitatively.
  • Clinical evaluation included physical examination, 6-minute walking test (6MWT), and questionnaires on pain, wheelchair use, and walking distance.

Main Results:

  • All patients exhibited hip dysplasia (acetabulum and os ilium) from a young age.
  • Acetabular coverage of the femoral head improved but remained insufficient over time.
  • Femoral head ossification abnormalities developed later, alongside reduced 6MWT distances and gait disturbances.

Conclusions:

  • Clinically significant hip abnormalities are a universal feature of MPS VI, evident early in life.
  • Os ilium and acetabular deformities precede femoral head abnormalities, likely due to altered biomechanics and GAG storage.
  • Individual variability in final femoral head morphology makes prediction challenging.